BrightSpring Health Services, Inc.

Listed Company

BTSGUCIK 0001865782NasdaqLarge AcceleratedServices-Home Health Care ServicesDelawareFY ends Dec 31

Period

FY 2025

Revenue

$12.91B

Net Income

$190.67M

Total Assets

$6.41B

Equity

$1.88B

Shares Out

193.54M

Op. Cash Flow

$490.17M

Business

BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform that delivers coordinated pharmacy and provider care to medically complex Senior and Specialty patients. It offers complementary services including infusion and specialty pharmacy, home and community pharmacy, medication therapy management (CCRx), home-based primary care, home health, hospice, rehab, supportive care, and community living and I/DD programs. The company’s operations are organized into two reportable segments: Pharmacy Solutions and Provider Services. Its services are delivered across all 50 U.S. states through local pharmacies, infusion centers, clinics, home visits, and institutional contracts with hospitals, senior living, behavioral providers, skilled nursing facilities, payors and PBMs.

Summary from filing dated 2025-03-06

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Total revenues	12,911	10,072	7,691	7,721
Cost of goods	10,507	8,009	5,841	4,635
Cost of services	885	797	711	1,731
Gross profit	1,518	1,266	1,139	1,354
Selling, general, and administrative expenses	1,223	1,158	1,081	1,126
Operating income	295	108	58	188
Loss on extinguishment of debt	—	13	—	—
Interest expense, net	157	191	272	234
Income (loss) from continuing operations before income taxes	138	−95	−214	−46
Income tax expense (benefit)	33	−26	−32	33
Net income (loss) from continuing operations	105	−69	−182	—
Income from discontinued operations, net of income taxes	84	48	25	—
Net income (loss)	189	−21	−157	−54
Net loss attributable to noncontrolling interests included in continuing operations	−2	−2	−2	−312,000
Net income (loss) attributable to BrightSpring Health Services, Inc. and subsidiaries	191	−18	−155	−54
Continuing operations	0.53	−0.34	−1.53	—
Discontinued operations	0.41	0.25	0.22	—
Net income (loss) per share	0.94	−0.09	−1.31	−0.46
Continuing operations	0.48	−0.34	−1.53	—
Discontinued operations	0.39	0.25	0.22	—
Net income (loss) per share	0.87	−0.09	−1.31	−0.46
Basic	203	193	118	118
Diluted	220	193	118	118

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	88	61	13	—	—
Accounts receivable, net of allowance for credit losses	990	903	882	—	—
Inventories	815	637	403	—	—
Prepaid expenses and other current assets	119	161	159	—	—
Total current assets	2,894	1,893	1,457	—	—
Property and equipment, net of accumulated depreciation of $404,878 and $339,892 at December 31, 2025 and 2024, respectively	205	181	246	—	—
Goodwill	2,546	2,364	2,301	2,576	—
Intangible assets, net of accumulated amortization	558	595	881	—	—
Operating lease right-of-use assets, net	172	161	267	—	—
Deferred income taxes, net	0	5	—	—	—
Other assets	40	39	73	—	—
Total assets	6,413	5,926	5,533	—	—
Trade accounts payable	1,218	924	642	—	—
Accrued expenses	333	296	492	—	—
Current portion of obligations under operating leases	43	39	71	—	—
Current portion of obligations under financing leases	7	3	11	—	—
Current portion of long-term debt	52	49	32	—	—
Total current liabilities	1,849	1,428	1,248	—	—
Obligations under operating leases, net of current portion	135	129	202	—	—
Obligations under financing leases, net of current portion	15	7	23	—	—
Long-term debt, net of current portion	2,455	2,562	3,332	—	—
Deferred income taxes, net	6	—	24	—	—
Long-term liabilities	67	71	92	—	—
Total liabilities	4,527	4,275	4,920	—	—
Redeemable noncontrolling interests	11	4	27	—	—
Common stock, $0.01 par value, 1,500,000,000 shares authorized, 192,124,125 and 174,245,990 shares issued and outstanding at December 31, 2025 and 2024, respectively	2	2	1	—	—
Preferred stock, $0.01 par value, 250,000,000 authorized; no shares issued and outstanding at December 31, 2025 and 2024	0	—	—	—	—
Additional paid-in capital	1,954	1,867	771	—	—
Accumulated deficit	−75	−222	−200	—	—
Accumulated other comprehensive (loss) income	−7	1	13	—	—
Total shareholders' equity	1,875	1,648	585	—	—
Noncontrolling interest	74,000	0	670,000	—	—
Total equity	1,875	1,648	585	755	775
Total liabilities, redeemable noncontrolling interests, and equity	6,413	5,926	5,533	—	—

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Depreciation and amortization	164	204	202	204
Impairment of long-lived assets	13	10	11	11
Change in fair value of contingent consideration, net	−1	2	—	—
Payment of contingent consideration in excess of acquisition date fair value	−6	−2	—	—
Provision for credit losses	56	34	23	15
Amortization of deferred debt issuance costs	11	12	21	20
Share-based compensation	70	69	4	4
Deferred income taxes, net	15	−26	−53	−28
Loss on disposition of fixed assets	2	101,000	349,000	−903,000
Other	−4	−2	−572,000	3
Accounts receivable	−131	−179	−127	−150
Prepaid expenses and other current assets	31	8	−35	−24
Inventories	−178	−237	29	−132
Trade accounts payable	264	303	106	133
Accrued expenses	32	−145	194	−46
Other assets and liabilities	−36	−21	−6	−5
Net cash provided by operating activities	490	24	211	−5
Purchases of property and equipment	−95	−81	−74	−70
Acquisitions of businesses, net of cash acquired	−205	−60	−63	−42
Other	−5	473,000	2	2
Net cash used in investing activities	−305	−140	−134	45
Long-term debt borrowings	—	2,566	—	—
Long-term debt repayments	−50	−3,396	−30	−41
Proceeds from issuance of common stock on initial public offering, net	—	656	—	—
Proceeds from issuance of tangible equity units, net	—	389	—	—
(Repayments) borrowings of the Revolving Credit Facility, net	−63	13	−24	−17
Payment of debt issuance costs	—	−47	—	—
Repurchase of shares of common stock	−43	−650,000	−650,000	—
Proceeds from shares issued under share-based compensation plan	25	2	598,000	234,000
Payment of taxes related to net share settlement of equity awards	−8	−1	—	—
Repurchase of stock options	—	—	−10	—
Payment of contingent consideration up to acquisition date fair value	−200,000	−2	−1	−4
Purchase of redeemable noncontrolling interest	−5	−2	—	—
Investment in noncontrolling interests	—	—	735,000	—
Payment of financing lease obligations	−14	−12	−12	−11
Net cash (used in) provided by financing activities	−158	165	−77	−74
Net increase (decrease) in cash and cash equivalents	27	48	−557,000	−33
Interest, net	184	211	304	213
Income taxes, net of refunds	27	25	37	29
Notes issued and contingent liabilities assumed in connection with acquisitions	—	22	8	5
Financing lease obligations (Note 13)	20	13	12	11
Repurchases of common stock in accounts payable	—	—	650,000	—
Purchases of property and equipment in accounts payable	7	12	13	5
Acquisition consideration in accounts payable	42	—	3	—
Consideration for purchase of redeemable noncontrolling interest in accounts payable	—	5	—	—
Shares issued in connection with acquisitions	—	31	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro